What a great question! – Listerine is noted in I-CARE RSV and FLU Treatment and the I-PREVENT: COVID, Flu and RSV
Here’s a bit of info I found:
“A class action lawsuit has been filed against Johnson & Johnson and Kenvue Inc., the manufacturers of Listerine mouthwash, alleging misleading marketing and potential health risks. The lawsuit claims that regular use of Listerine, particularly the Cool Mint variety, may lead to the proliferation of bacteria associated with colorectal cancer.
Key points of the lawsuit include:
The suit cites a study suggesting that twice-daily use of Listerine mouthwash may increase the presence of fusobacterium species in the oral cavity1.
Fusobacterium, typically found in the mouth, has been associated with increased tumors in colorectal cancer patients.
The lawsuit alleges that Listerine does not warn consumers about potential risks and claims health benefits that may be controversial. It argues that the product fails to display warnings regarding cancer risk.
The case, filed on September 3, 2024, is titled “Vasseur v. Johnson & Johnson Consumer, Inc. et al.” and is pending in the United States District Court for the Central District of California2.
It’s important to note that while the lawsuit cites studies showing associations, there is currently no proven causation between Listerine use and colorectal cancer. Kenvue, the current manufacturer of Listerine, maintains that the mouthwash has no relationship to colorectal cancer or any other type of cancer.”
I’ll bounce this question to my medical colleagues and let’s see what they say.
covid19criticalcare.com
I-CARE: RSV and Flu Treatment - FLCCC Alliance
I-CARE RSV and FLU Treatment Download I-CARE RSV and Flu Summary Download I-CARE RSV and Flu Protocol A Guide to Diagnosing and Managing Influenza and Respiratory Syncytial Virus (RSV) Infections in Adults In adult patients, COVID-19 (Omicron